What is the major cause of sudden cardiac death in adults less than 40 years of age? And, uh, in, uh, uh, in g- patients, what is the sudden cause of death? And in old- older patients, what is the sudden c- cause of death?

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Excellent - I now have very clear, comprehensive information from the textbooks. Here is the full answer:

Sudden Cardiac Death (SCD) - By Age Group

In Adults < 35-40 Years (Young Patients)

The major cause is hypertrophic cardiomyopathy (HCM), which accounts for about 36% of cases in young U.S. athletes. It is the most common cardiovascular cause of SCD in young athletes.
The full breakdown for young patients includes:
CauseNotes
Hypertrophic cardiomyopathy#1 cause (~36%)
Coronary artery anomalies~17%
Aortic rupture / Marfan syndrome-
Dilated cardiomyopathy-
Myocarditis-
Arrhythmogenic right ventricular cardiomyopathy (ARVC)-
Commotio cordis~3%, blunt chest trauma triggering VF
Mitral valve prolapse-
Hereditary channelopathies (Long QT, Brugada, etc.)-
The underlying mechanism in these structural diseases is a ventricular arrhythmia (typically ventricular fibrillation) triggered by the structural abnormality.
"The cause of sudden cardiac death in young athletes (younger than 35 years) is usually a structural cardiac abnormality, with hypertrophic cardiomyopathy and coronary artery anomalies representing 36% and 17% of U.S. cases, respectively." - Textbook of Family Medicine, 9e

In Older Adults (> 35-40 Years)

The dominant cause shifts completely to atherosclerotic coronary artery disease (CAD), which accounts for >75% of SCD in older athletes/adults, and is present in autopsy findings in up to 80% of all SCD victims in the general adult population.
  • Coronary artery disease: ~80% of all adult SCD cases
  • Cardiomyopathy (primarily dilated, with reduced ejection fraction): 10-15%
  • Other (valvular disease, channelopathies, congenital anomalies): 5-10%
The prevalence of SCD is greatest in adults over 45-50 years, with 60% occurring in males. CAD is often undiagnosed before the event - approximately one-third of victims show evidence of acute plaque rupture at autopsy.
"Coronary artery disease (which is often undiagnosed before the event) is the major cause of sudden cardiac death in adults and is present in 80% of cases." - Tintinalli's Emergency Medicine
"In older athletes (older than 35 years of age), atherosclerotic CAD accounts for more than 75% of cases of sudden cardiac death." - Textbook of Family Medicine, 9e

Quick Summary

Age Group#1 Cause of SCD
< 35 years (young)Hypertrophic cardiomyopathy (HCM)
> 35-40 years (older adults)Atherosclerotic coronary artery disease (CAD)
The key turning point is around age 35. Below this, structural/genetic conditions dominate; above it, atherosclerosis takes over as the overwhelming cause.

The ends of the terminal sarcomeres of cardiac muscle insert into a specialized structure that helps stabilize c unctional complex between apposing muscle cells, and to aid in transmitting the contractile forces from cell to ell. This specialized structure is referred to as the zona adherens macula adhereng fascia adherentes macula densa nexus

Finding Sources
Finding Sources
Reading File
The answer is C. Fascia adherentes (fascia adherens).
Here is the full explanation from the textbook:

Fascia Adherentes (Fascia Adherens)

The fascia adherens (FA) is the major constituent of the transverse component of the intercalated disc - the specialized junctional complex located at the ends of cardiac muscle cells where apposing cells meet.

What it does:

  • Anchors the thin filaments of terminal sarcomeres onto the plasma membrane (sarcolemma)
  • Holds cardiac muscle cells at their ends to form the functional cardiac muscle fiber
  • Transmits contractile forces from one cell to the next across the junction
  • It is the largest and most prominent component of the intercalated disc, occupying a much larger area than the macula adherens

Structure of the Intercalated Disc (all 3 components):

ComponentLocation in discFunction
Fascia adherensTransverse componentAnchors terminal sarcomere thin filaments; transmits force
Macula adherentes (desmosomes)Transverse + lateral componentsReinforces the FA; resists mechanical stress
Gap junctions (nexus)Lateral component ONLYElectrical coupling between cells (ion passage)

Why the other options are wrong:

  • Zona adherens - the analogous structure in epithelial cells, not cardiac muscle (the FA is the cardiac equivalent)
  • Macula adherens - desmosomes; they reinforce the FA but are not where thin filaments insert
  • Macula densa - a renal tubular structure involved in juxtaglomerular apparatus sensing; completely unrelated
  • Nexus - another name for gap junctions; these are in the lateral component and handle electrical conduction, not sarcomere anchoring
"The fascia adherens serves as the site at which the thin filaments in the terminal sarcomere anchor onto the plasma membrane... The FA of the intercalated disc corresponds to the zonula adherens of epithelial tissues." - Histology: A Text and Atlas, p. 846-847
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Answers in detail

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here are detailed answers to all 10 questions:

Q1. The following structures are found in the superior mediastinum, EXCEPT:

Answer: B. Azygos vein
The superior mediastinum (above the sternal angle/T4-T5 disc level) contains:
  • Thymus (E) - lies anteriorly
  • Brachiocephalic veins (D) - right and left, forming the SVC
  • Arch of the aorta (C) with its 3 branches (brachiocephalic trunk, left common carotid, left subclavian)
  • Phrenic nerves (A), vagus nerves, left recurrent laryngeal nerve
  • Trachea, esophagus, thoracic duct
The azygos vein (B) runs in the posterior mediastinum along the right side of the vertebral column. Only the arch of the azygos vein arches over the root of the right lung and drains into the SVC, but the main azygos venous system is posterior mediastinal, NOT a superior mediastinal structure.

Q2. Stab wound in the left 5th intercostal space, 8 cm from the midline. What structure is most likely damaged?

Answer: A. Apex of the heart
  • The heart's apex lies at the left 5th intercostal space, midclavicular line - approximately 8-9 cm from the midline.
  • At this precise location (left 5th ICS, ~8 cm from sternum), the apex of the heart is the most superficial and vulnerable cardiac structure.
  • The lateral basal segment of the left lung would be more lateral (>10 cm).
  • The left kidney is retroperitoneal, far below this level.
  • The spleen and left lobe of liver are sub-diaphragmatic, not at the 5th ICS level.
The classic teaching is: apex beat = left 5th ICS, midclavicular line (~9 cm from midline). A wound 8 cm from the midline at the 5th ICS hits the cardiac apex.

Q3. Lymph flow from the foot is:

Answer: D. Increased when the foot is massaged
Analysis of each option:
  • A. Decreased when valves of leg veins are incompetent - FALSE. Incompetent venous valves cause venous pooling/edema, which actually INCREASES interstitial fluid and thus lymph formation and flow.
  • B. Decreased in exercise - FALSE. Exercise increases muscle pump activity, venous return, and lymphatic flow.
  • C. Increased when capillary permeability is decreased - FALSE. Decreased permeability means less fluid leaks into interstitium, so less lymph is formed.
  • D. Increased when the foot is massaged - TRUE. Massage mechanically compresses lymphatics and propels lymph forward (used clinically in manual lymphatic drainage therapy).
  • E. Increased when an individual rises from supine to standing - FALSE. Standing increases hydrostatic pressure in the foot, but the net effect on lymph flow from the foot is NOT increased; gravity impedes upward lymph transport. Lymphedema worsens with prolonged standing.

Q4. The following structures are contained in the posterior mediastinum, EXCEPT:

Answer: D. Internal thoracic artery
The posterior mediastinum (behind the pericardium, in front of vertebrae T5-T12) contains:
  • Descending (thoracic) aorta (A)
  • Esophagus (B)
  • Thoracic duct (C)
  • Azygos venous system (hemiazygos, accessory hemiazygos) (E)
  • Sympathetic trunks, splanchnic nerves, vagus nerves
The internal thoracic artery (D) - also called internal mammary artery - runs just lateral to the sternum inside the anterior chest wall, not in the posterior mediastinum. It is NOT a mediastinal structure at all.

Q5. Elastic fiber is stained by:

Answer: A. File stain (Verhoeff-van Gieson stain)
Special stains for elastic fibers:
  • Verhoeff-van Gieson (VVG) / Verhoeff's elastic stain - the classic, most commonly used stain for elastic fibers; stains them black against a yellow (connective tissue) background. This is sometimes called the "file stain" or elastic tissue stain.
  • Weigert's resorcin-fuchsin stain - also stains elastic fibers blue-black.
  • Von Kossa stain (B) - stains calcium deposits (mineralization), NOT elastic fibers.
  • PAS stain (C) - stains glycogen, mucus, basement membranes (polysaccharides with vicinal diols), NOT elastic fibers.
  • Alkaline Congo Red (D) - stains amyloid (apple-green birefringence under polarized light), NOT elastic fibers.

Q6. Acute rheumatic heart disease is characterized by all of the following EXCEPT:

Answer: E. Fusion of the valve commissures
Features of ACUTE rheumatic heart disease:
  • A. Myocarditis - YES, present in acute phase (pancarditis - affects all three layers)
  • B. Fibrinous pericarditis - YES ("bread and butter" pericarditis), characteristic of acute phase
  • C. MacCallum plaques on the atrial endocardium - YES, jet lesions on the posterior left atrial wall from regurgitant valvular flow
  • D. Aschoff bodies in myocardium - YES, pathognomonic granulomas of acute rheumatic carditis; contain Aschoff giant cells, Anitschkow cells (caterpillar cells)
  • E. Fusion of valve commissures - NO, this is a feature of CHRONIC (healed) rheumatic heart disease. After repeated episodes, scarring leads to commissural fusion causing mitral stenosis. In the ACUTE phase, only small verrucae (vegetations) form along valve closure lines; the valves are not yet fused.

Q7. Graham Steell murmur is generated from:

Answer: E. Pulmonary valve
  • The Graham Steell murmur is a high-pitched, early diastolic, decrescendo murmur heard best at the left 2nd interspace (pulmonary area), radiating along the left sternal border.
  • It is caused by pulmonary regurgitation (PR) secondary to pulmonary hypertension - the dilated pulmonary artery ring causes the pulmonary valve to become incompetent.
  • The regurgitant flow is from the pulmonary valve back into the right ventricle during diastole.
  • Classically seen in severe mitral stenosis (causing pulmonary hypertension), primary pulmonary hypertension, or Eisenmenger syndrome.
  • It can be difficult to distinguish from aortic regurgitation murmur, but the Graham Steell originates from the pulmonary valve, not the aortic valve.

Q8. The tricuspid area is:

Answer: A. The left fifth interspace just to the left of the sternum
Cardiac auscultation areas:
Valve AreaLocation
AorticRight 2nd ICS, right sternal border
PulmonaryLeft 2nd ICS, left sternal border
TricuspidLeft 4th-5th ICS, left sternal border (lower left sternal border)
Mitral (Apex)Left 5th ICS, midclavicular line
The tricuspid area is at the lower left sternal border - the left 4th or 5th intercostal space just to the LEFT of the sternum (not the midclavicular line, and not the right side). Option A best describes this.

Q9. The S1 heart sound is increased in all of the following situations and disorders EXCEPT:

Answer: B. Anemia
S1 is produced by closure of the mitral and tricuspid valves at the start of systole. S1 is louder when valve leaflets are wide open at end-diastole and snap shut forcefully.
S1 is increased in:
  • A. Exercise - increased sympathetic drive, faster heart rate, more forceful valve closure
  • C. Hyperthyroidism - increased cardiac output and sympathetic tone
  • D. First degree heart block - long PR interval allows mitral leaflets to drift apart widely before systole, so they snap shut from a wider open position = louder S1
  • E. Mitral stenosis - pliable but stiff leaflets snap shut loudly (when not heavily calcified)
S1 is NOT increased in anemia (B). Anemia causes a hyperdynamic circulation, but S1 intensity depends on valve motion, not simply on cardiac output. Anemia does not specifically amplify S1 - it causes flow murmurs (systolic), not a louder S1. In fact, severe anemia with cardiac dilation can lead to a softer S1.

Q10. Syncope may be due to the following EXCEPT:

Answer: A. Myocardial infarction
Syncope is a transient loss of consciousness due to global cerebral hypoperfusion, with rapid spontaneous recovery.
Causes of cardiac syncope include:
  • B. Mitral stenosis - obstructed cardiac output, especially with exertion
  • C. Arrhythmias - very common cause (VT, complete heart block, sick sinus syndrome)
  • D. Aortic stenosis - classic triad: angina, dyspnea, syncope (exertional)
  • E. Hypertrophic cardiomyopathy - outflow tract obstruction causes exertional syncope
A. Myocardial infarction does NOT typically cause syncope. MI causes chest pain, arrhythmias, and cardiogenic shock but syncope is not a classic or direct feature of MI itself. While arrhythmias secondary to MI can cause syncope, MI per se is not listed as a direct cause of syncope in standard classifications. The question asks what syncope is due to "EXCEPT" - MI is the odd one out because it causes myocardial damage rather than the mechanical outflow obstruction or primary arrhythmia that directly produces syncope.
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Answer in detail

I can read all 10 questions clearly from the images. Let me answer them all in detail right away.

Q1. Cheyne-Stokes breathing may be improved by the administration of:

  1. dyphylline
  2. theophylline
  3. aminophylline
  4. oxtriphylline
Answer: C. 2 and 4 (or by some sources: A. 3 and 4, or E. 1, 2 and 3 — but the standard answer is that xanthine derivatives help)
Actually, let me clarify precisely:
Answer: E. 1, 2 and 3 — All xanthine derivatives improve Cheyne-Stokes breathing.

Explanation:

Cheyne-Stokes breathing is a pattern of cyclical crescendo-decrescendo breathing alternating with apnea. It occurs because of increased circulatory time (heart failure) or CNS dysfunction causing oscillations in CO₂ sensitivity.
The xanthine/methylxanthine derivatives used to treat it:
  • Theophylline (2) - the most established; acts as a respiratory stimulant by blocking adenosine receptors and stimulating the medullary respiratory center; increases hypercapnic ventilatory response and reduces apneic threshold
  • Aminophylline (3) - a soluble salt of theophylline (theophylline + ethylenediamine); same mechanism; given IV in acute settings
  • Dyphylline (1) - a theophylline derivative with similar bronchodilator/respiratory stimulant effects
  • Oxtriphylline (4) - choline salt of theophylline; similar class
All four are xanthine derivatives that stimulate the respiratory center. Options 1, 2, 3, and 4 all have the same class mechanism. The best answer is E (1, 2, and 3) if the question excludes oxtriphylline, but most standard teaching includes theophylline and aminophylline as the key drugs. The circled answer in the image appears to be C (2 and 4).
Bottom line: Theophylline and aminophylline (and related xanthines) improve Cheyne-Stokes breathing by:
  1. Stimulating the medullary respiratory center
  2. Increasing sensitivity to CO₂
  3. Reducing the length of the apneic phase

Q2. Standard limb lead III of the ECG represents cardiac potential differences as they occur between:

Answer: B. Left arm and left leg

Explanation:

Einthoven's triangle defines the three standard limb leads:
LeadPositive electrodeNegative electrodeMeasures
Lead ILeft arm (LA)Right arm (RA)LA - RA
Lead IILeft leg (LL)Right arm (RA)LL - RA
Lead IIILeft leg (LL)Left arm (LA)LL - LA
Lead III = Left leg MINUS left arm (left leg is positive, left arm is negative).
Einthoven's Law: Lead II = Lead I + Lead III
The right leg electrode is the ground/reference only and does not contribute to any standard lead measurement.
  • A. Left arm and right leg - incorrect (that would be a modified lead)
  • B. Left arm and left leg - CORRECT
  • C. Right arm and left arm - this is Lead I
  • D. Right arm and left leg - this is Lead II
  • E. Right arm and right leg - incorrect (right leg = ground)

Q3. A middle-aged patient with elevated serum creatinine, hypertension, and mild anemia comes for evaluation. Urine dipstick shows trace protein without red cells or cellular casts. A 24-h urine collection reveals 5 g of protein. The most likely etiology is:

Answer: B. Amyloidosis

Explanation:

The key clinical features to analyze:
  • Elevated creatinine - chronic kidney disease
  • Hypertension
  • Mild anemia (chronic kidney disease-related)
  • Urine dipstick: TRACE protein - this is the critical clue
  • 24-h urine: 5 g protein = nephrotic-range proteinuria (>3.5 g/day)
The paradox: dipstick shows only trace protein, but 24-h collection shows massive 5 g proteinuria.
This discrepancy occurs because dipstick detects albumin selectively. In conditions where the protein excreted is NOT albumin (e.g., light chains, immunoglobulins), the dipstick will be falsely low/negative while the actual protein load is very high.
Amyloidosis (B):
  • Amyloid deposits in glomeruli cause heavy proteinuria
  • The proteinuria in amyloidosis can be non-albumin light chains (AL amyloid) or mixed
  • Middle age + anemia + renal failure + discrepant dipstick vs. 24-h protein is classic for amyloidosis
  • The key clue is the discrepancy between trace dipstick and 5 g/24h urine protein - suggesting non-albumin proteins (Bence-Jones protein / light chains)
Why not the others:
  • A. Focal segmental glomerulosclerosis (FSGS) - would give albumin-type proteinuria; dipstick would be markedly positive
  • C. Hypertensive nephrosclerosis - typically gives low-level proteinuria (<1 g/day), not 5 g
  • D. Multiple myeloma - also gives light chain (Bence-Jones) proteinuria with dipstick-negative result, BUT the question says "middle-aged" and mild anemia, and amyloidosis (often secondary to myeloma) fits better in this constellation
Note: If options included multiple myeloma AND amyloidosis, the distinction is that amyloidosis is a known cause of nephrotic syndrome with dipstick-negative (trace) proteinuria due to light chain deposition - making B the best answer.

Q4. A 32-year-old homosexual male presents with recurrent bleeding episodes from the gastrointestinal tract. Which of the following is the most likely cause of his GI bleeding?

Answer: B. Kaposi's sarcoma

Explanation:

The key clues:
  • 32-year-old homosexual male → high-risk for HIV/AIDS
  • Recurrent GI bleeding
In an HIV-positive homosexual male, the differential for GI bleeding includes AIDS-defining illnesses:
  • A. Giardiasis - causes diarrhea, malabsorption, NOT typically GI bleeding
  • B. Kaposi's sarcoma - CORRECT. KS involves the GI tract in >50% of patients with cutaneous KS; GI KS is the most common cause of GI bleeding in HIV patients. It causes submucosal vascular lesions that bleed.
  • C. Cryptosporidiosis - causes profuse watery diarrhea, NOT bleeding
  • D. Tuberculosis - can cause GI involvement but not the most common cause of GI bleeding in this context
  • E. Amebiasis - can cause bloody diarrhea, but not the most likely in an HIV+ homosexual male with recurrent bleeding
Kaposi's sarcoma is caused by HHV-8 (Human Herpesvirus 8), is strongly associated with HIV/AIDS in MSM (men who have sex with men), and GI tract involvement (stomach, small intestine, colon) causes painless recurrent hemorrhage.

Q5. Syncope may be due to the following EXCEPT:

Answer: A. Myocardial infarction
(This is the same question from the previous set - already answered in detail above)
Syncope = transient loss of consciousness from global cerebral hypoperfusion.
  • B. Mitral stenosis - obstructed LV filling → reduced cardiac output → syncope ✓
  • C. Arrhythmias - most common cardiac cause of syncope ✓
  • D. Aortic stenosis - classic cause of exertional syncope (fixed obstruction) ✓
  • E. Hypertrophic cardiomyopathy - dynamic LVOT obstruction causes exertional syncope ✓
  • A. Myocardial infarction - causes chest pain, arrhythmia, and cardiogenic shock; not a direct/primary cause of syncope itself

Q6. The tricuspid area (for a medical student told to auscultate tricuspid murmurs):

Answer: E. The left fifth interspace just to the left of the sternum

Explanation:

The standard cardiac auscultation areas:
AreaLocation
AorticRight 2nd ICS, right sternal border
PulmonaryLeft 2nd ICS, left sternal border
Erb's pointLeft 3rd ICS, left sternal border
TricuspidLeft 4th-5th ICS, left lower sternal border
Mitral (apex)Left 5th ICS, midclavicular line
The tricuspid area is at the lower left sternal border - the left 5th intercostal space, just to the LEFT of the sternum (not the midclavicular line). This makes E correct.
  • A. Second interspace to the right = Aortic area
  • B. Second interspace just to the left = Pulmonary area
  • C. Right fifth interspace to the right = Not a standard area
  • D. Left fifth interspace medial to midclavicular line = Mitral/apex area
  • E. Left fifth interspace just to the left of the sternum = Tricuspid area ✓

Q7. Pulsus paradoxus means:

Answer: E. Decrease of the systolic BP ≥ 8 mm Hg with normal respiration

Explanation:

Pulsus paradoxus is defined as an exaggerated fall in systolic blood pressure during normal (quiet) inspiration of ≥10 mmHg (some sources say ≥8 mmHg - which matches option E).
Physiology:
  • During inspiration, intrathoracic pressure falls → pulmonary vasculature expands → more blood pools in pulmonary circulation → less returns to left heart → LV stroke volume decreases → systolic BP falls slightly
  • Normally this fall is <10 mmHg
  • In pulsus paradoxus, this normal inspiratory fall is greatly exaggerated (≥10 mmHg)
The "paradox": The pulse disappears/weakens on inspiration even though the heart is still beating (you can hear the heart but not feel the pulse).
Causes:
  • Cardiac tamponade (classic)
  • Severe asthma / COPD
  • Constrictive pericarditis (sometimes)
  • Tension pneumothorax
Why each option is wrong:
  • A. Increase of pulse with normal respiration - opposite direction
  • B. Increase of systolic BP ≥8 mm with normal respiration - wrong direction
  • C. Increase of diastolic BP ≥8 mm with normal respiration - wrong parameter + wrong direction
  • D. Decrease of the pulse with normal respiration - describes the pulse disappearing but doesn't quantify the BP change (incomplete definition)
  • E. Decrease of systolic BP ≥8 mm with normal respiration - CORRECT ✓

Q8. Which of the following tumors occur most frequently in the posterior mediastinum?

Answer: E. Neurogenic tumors

Explanation:

The "Rule of 3s" for mediastinal compartments and their characteristic masses:
CompartmentMost common tumors
AnteriorThymoma, Teratoma/germ cell, Thyroid, Terrible lymphoma ("4 T's")
MiddleLymphoma, pericardial cysts, bronchogenic cysts
PosteriorNeurogenic tumors (most common!)
Posterior mediastinal masses arise from the paravertebral sympathetic chain and intercostal nerves:
  • Schwannoma / neurofibroma (benign nerve sheath tumors) - most common overall posterior mediastinal tumors in adults
  • Neuroblastoma, ganglioneuroblastoma - in children
  • Ganglioneuroma - in adults/older children
  • Paraganglioma
Why others are wrong:
  • A. Parathyroid tumors - rare, found in anterior/superior mediastinum (ectopic parathyroid)
  • B. Thyroid tumors - anterior/superior mediastinum (substernal goiter)
  • C. Lymphomas - anterior or middle mediastinum
  • D. Thymomas - exclusively in the anterior mediastinum (thymus)
  • E. Neurogenic tumors - CORRECT ✓ - most common posterior mediastinal tumors (~75% of posterior mediastinal masses)

Q9. Large bounding pulses are associated with all of the following EXCEPT:

Answer: A. Aortic stenosis

Explanation:

Large bounding (high volume / "water hammer") pulses occur when there is a large pulse pressure (wide difference between systolic and diastolic BP). This happens with high stroke volume or rapid runoff of blood.
Causes of large bounding pulse:
  • B. Fever - vasodilation, hyperdynamic circulation, increased HR and stroke volume ✓
  • C. Aortic regurgitation - classic cause; large forward stroke volume + diastolic runoff back into LV → wide pulse pressure (Corrigan's/water hammer pulse) ✓
  • D. Anemia - hyperdynamic circulation ✓
  • E. Hyperthyroidism - increased cardiac output, tachycardia, vasodilation ✓
A. Aortic stenosis causes a SMALL, slow-rising pulse ("pulsus parvus et tardus" = small and late). The aortic outflow obstruction reduces stroke volume and prolongs ejection time, resulting in a weak, plateau-type pulse - the exact opposite of a bounding pulse.

Q10. P wave on ECG represents:

Answer: E. Depolarization of the atria

Explanation:

The ECG waveforms and their meanings:
ECG ComponentRepresents
P waveAtrial depolarization (SA node → atrial muscle)
PR intervalAV nodal conduction delay
QRS complexVentricular depolarization
ST segmentPlateau phase of ventricular action potential
T waveVentricular repolarization
U waveLate ventricular repolarization / His-Purkinje repolarization
Note: Atrial repolarization is NOT visible on the ECG - it is hidden within the QRS complex.
  • A. Repolarization of ventricles = T wave
  • B. Contraction of ventricles = occurs after QRS (mechanical event)
  • C. Contraction of atria = mechanical event after P wave (not the wave itself)
  • D. Depolarization of ventricles = QRS complex
  • E. Depolarization of the atria = P wave ✓
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Answer in detail

I can read all 10 questions clearly. Here are detailed answers for each:

Q1. Which of the following ECGs is characteristic for sinus bradycardia?

Answer: A (the ECG strip shown as option A)

Explanation:

Sinus bradycardia is defined as a heart rate < 60 beats per minute originating from the SA node.
ECG criteria for sinus bradycardia:
  • Rate: < 60 bpm (R-R interval > 5 large squares = 1 second)
  • P wave: Present, upright in lead II, before every QRS
  • PR interval: Normal (0.12-0.20 sec)
  • QRS: Normal morphology and duration
  • Rhythm: Regular
In the image, Option A shows widely spaced but normal-morphology complexes with regular P waves before each QRS - consistent with sinus bradycardia. Option B shows irregular/rapid activity (likely atrial fibrillation), and Option C shows a faster regular rhythm.
Causes of sinus bradycardia:
  • Athletes (physiological)
  • Hypothyroidism
  • Increased vagal tone
  • Beta-blockers, digoxin, calcium channel blockers
  • Inferior MI (RCA supplies SA node in 60% of people)
  • Sick sinus syndrome
  • Hypothermia

Q2. The therapeutic action of cardiac glycosides on mechanical function is:

Answer: G. All of the above

Explanation - breaking down each statement:

A. To increase the intensity of the interaction of the actin and myosin filaments of the cardiac sarcomere - TRUE. The ultimate mechanical effect of digoxin is enhanced actin-myosin cross-bridge cycling, producing stronger contraction (positive inotropy).
B. The intensity is caused by an increase in the free calcium concentration in the vicinity of the contractile proteins during systole - TRUE. The mechanism of cardiac glycosides is:
  1. Inhibit Na⁺/K⁺-ATPase pump → intracellular Na⁺ accumulates
  2. Na⁺ buildup inhibits the Na⁺/Ca²⁺ exchanger (NCX) - normally, NCX exports Ca²⁺ out; with high intracellular Na⁺, less Ca²⁺ is expelled
  3. Result: more Ca²⁺ stored in the sarcoplasmic reticulum
  4. On subsequent depolarization, more Ca²⁺ is released into the vicinity of the myofibrils → increased actin-myosin interaction
C. The increase in calcium concentration is the result of a two-step process - TRUE. The two steps are: (1) Na⁺/K⁺-ATPase inhibition → intracellular Na⁺ rises, then (2) Na⁺/Ca²⁺ exchanger is secondarily inhibited → intracellular Ca²⁺ rises.
D. The duration of the contractile response is neither shortened nor prolonged - TRUE. Cardiac glycosides increase the force (amplitude) of contraction without significantly altering the duration of systole. This distinguishes them from catecholamines, which can shorten contraction duration.
Since A, B, C, and D are all true → G. All of the above is the correct answer.

Q3. α₂-adrenoceptors are distributed in all of the following locations EXCEPT:

Answer: E. Heart

Explanation:

α₂-adrenoceptors are found at:
LocationRole
A. Fat cells (adipocytes)α₂ inhibits lipolysis (anti-lipolytic effect) ✓
B. Plateletsα₂ on platelets promotes platelet aggregation ✓
C. Postsynaptic CNS adrenoceptorsα₂ in brain (e.g., locus coeruleus) - basis of clonidine's central antihypertensive effect ✓
D. Adrenergic and cholinergic nerve terminalsα₂ are presynaptic autoreceptors that inhibit NE release (negative feedback); also found on cholinergic terminals as heteroreceptors ✓
E. HeartThe heart contains β₁ receptors (dominant) and some α₁. α₂ receptors are NOT a significant presence in cardiac muscle
The heart's adrenergic pharmacology is dominated by β₁ receptors (positive inotropy/chronotropy). α₂ receptors are NOT found in the heart.

Q4. A 55-year-old female with BP 170/105 mmHg has pitting edema of the lower extremities and elevated serum creatinine associated with normal serum potassium. Which of the following agents is contraindicated?

Answer: B. Acetazolamide

Explanation:

Clinical context analysis:
  • Hypertension → needs antihypertensive/diuretic
  • Pitting edema → needs a diuretic
  • Elevated serum creatininechronic kidney disease (CKD)
  • Normal serum potassium
Now evaluate each diuretic:
  • A. Ethacrynic acid - loop diuretic; works even in renal failure; safe in CKD (in fact it's the only loop diuretic usable in patients allergic to sulfa); NOT contraindicated
  • B. Acetazolamide - carbonic anhydrase inhibitor; acts on the proximal tubule; requires functioning tubules and a normal GFR to work; in renal failure/elevated creatinine, it is INEFFECTIVE and CONTRAINDICATED because: (1) it won't work properly without functioning nephrons, (2) it can cause hyperchloremic metabolic acidosis which is dangerous in CKD patients who already have impaired acid-base handling
  • C. Metolazone - thiazide-like diuretic (works at distal tubule); notably, unlike regular thiazides, metolazone works even at low GFR - a key distinguishing fact; NOT contraindicated in CKD
  • D. Hydrochlorothiazide - standard thiazide; becomes less effective at GFR <30; at this patient's level it may still work; not strictly contraindicated
  • E. Triamterene - K⁺-sparing diuretic; with normal K⁺ and CKD, there is a risk of hyperkalemia, but it is not the MOST contraindicated here
Answer: B. Acetazolamide is contraindicated because it is ineffective and potentially harmful in renal impairment.

Q5. H₁-histamine antagonists frequently affect the autonomic nervous system by acting as:

Answer: E. Muscarinic antagonists

Explanation:

H₁ antihistamines (first-generation: diphenhydramine, promethazine, chlorpheniramine, etc.) have significant anticholinergic (antimuscarinic) side effects due to structural similarity between their pharmacophore and atropine.
This is why first-generation antihistamines cause:
  • Dry mouth
  • Urinary retention
  • Constipation
  • Blurred vision
  • Tachycardia
  • Sedation (CNS muscarinic blockade)
Analysis of options:
  • A. Muscarinic agonists - WRONG: they BLOCK, not stimulate, muscarinic receptors
  • B. α₁-agonists - WRONG: not a recognized effect
  • C. Cholinesterase inhibitors - WRONG: these would increase ACh levels (opposite effect)
  • D. Blockers of acetylcholine release - WRONG: H₁ antihistamines block the receptor, not ACh release
  • E. Muscarinic antagonists - CORRECT ✓
Second-generation antihistamines (cetirizine, loratadine, fexofenadine) have minimal anticholinergic effects due to their larger molecular size and poor CNS penetration.

Q6. In a patient undergoing warfarin therapy, which of the following factors is measured in the partial thromboplastin time (PTT) rather than the prothrombin time (PT)?

Answer: C. Factor IX

Explanation:

Warfarin inhibits Vitamin K-dependent clotting factors: II, VII, IX, X (and Protein C and S).
PT (Prothrombin Time) measures the extrinsic + common pathway:
  • Factor VII (extrinsic)
  • Factor X, V, II, fibrinogen (common)
  • PT/INR is the test used to monitor warfarin because Factor VII has the shortest half-life and changes earliest
aPTT (Partial Thromboplastin Time) measures the intrinsic + common pathway:
  • Factors XII, XI, IX, VIII (intrinsic - "contact pathway")
  • Factor X, V, II, fibrinogen (common)
Now the question asks: among the answer choices, which factor is measured by PTT (not PT)?
FactorPathway
A. Factor XCommon pathway - measured by BOTH PT and PTT
B. Factor XIIntrinsic pathway - measured by PTT only
C. Factor IXIntrinsic pathway - measured by PTT
D. Factor VIIExtrinsic - measured by PT only
E. Factor IICommon pathway - measured by both
Factor IX is in the intrinsic pathway only → measured by PTT, not PT. Even though warfarin inhibits Factor IX, its effect on Factor IX is detected via the PTT, not the PT. The PT (and INR) remains the clinical monitoring tool for warfarin because of Factor VII's early response.
Answer: C. Factor IX

Q7. In the treatment of clonidine withdrawal syndrome, propranolol should be combined with:

Answer: A. Phentolamine (in image a.jpg) / C. Phentolamine (in image ccc.jpg)

Explanation:

Clonidine is a centrally acting α₂ agonist used for hypertension. It stimulates presynaptic α₂ receptors in the brainstem → reduces sympathetic outflow → lowers BP and HR.
Clonidine withdrawal syndrome:
  • Abrupt discontinuation causes massive rebound sympathetic activation
  • Surging norepinephrine release stimulates peripheral α₁ and β₁ receptors
  • Causes: severe hypertension, tachycardia, sweating, anxiety
Why propranolol alone is DANGEROUS in clonidine withdrawal:
  • Propranolol (non-selective β-blocker) blocks β₁ (heart) and β₂ (vasodilation in peripheral vessels)
  • With β₂ receptors blocked, the peripheral vasculature is left with only unopposed α₁ stimulation by the surging NE
  • This causes severe reflex hypertension (vasoconstriction without vasodilation)
Why you MUST combine propranolol with phentolamine:
  • Phentolamine is a non-selective α-blocker (blocks α₁ and α₂)
  • It counteracts the peripheral α₁-mediated vasoconstriction
  • Together: propranolol controls heart rate + phentolamine controls BP → safe management
Why not the others:
  • Cromakalim / Pinacidil - K⁺ channel openers (vasodilators); not the appropriate combination here
  • Phenoxybenzamine - irreversible α-blocker; used in pheochromocytoma prep, not standard for clonidine withdrawal
  • Urapidil - α₁ blocker + 5-HT1A agonist; not the classic answer
Answer: A/C Phentolamine

Q8. β₃-adrenoceptors are found in:

Answer: C. Fat cells

Explanation:

β₃-adrenoceptors have a very specific and limited distribution. The classic and primary location is adipose tissue (fat cells).
AdrenoceptorPrimary locations
β₁Heart, kidneys (JGA), salivary glands
β₂Bronchial smooth muscle, uterus, skeletal muscle vasculature, liver
β₃Adipose tissue (fat cells), urinary bladder detrusor
β₃ function in fat cells: Stimulation causes thermogenesis and lipolysis (breakdown of triglycerides → free fatty acids). This is why β₃ agonists have been investigated as anti-obesity drugs.
Clinically approved β₃ agonist: Mirabegron (Myrbetriq) - used for overactive bladder (acts on detrusor muscle β₃ receptors to promote bladder relaxation).
Analysis of wrong options:
  • A. Pilomotor smooth muscle - contains α₁ receptors (causes piloerection)
  • B. Pupillary dilator muscle - contains α₁ receptors (mydriasis)
  • D. Human liver - contains β₂ and α₁ receptors (glycogenolysis)
  • E. Nerve endings - contain α₂ presynaptic receptors
Answer: C. Fat cells

Q9. In the treatment of clonidine withdrawal syndrome, propranolol should be combined with: (repeated version with different option order)

Answer: A. Phentolamine
(Same explanation as Q7 above - see detailed reasoning there)
The correct combination is propranolol + phentolamine to manage the rebound sympathetic storm from clonidine withdrawal, blocking both the β-mediated tachycardia (propranolol) and the α-mediated severe hypertension (phentolamine).

Q10. All of the following are true about spironolactone EXCEPT:

Answer: A. Its adverse effects are hypokalemia, agitation, and skin rashes

Explanation:

Spironolactone is a potassium-sparing diuretic and aldosterone antagonist (competitive antagonist at mineralocorticoid receptors in the collecting duct).
Evaluate each statement:
A. Its adverse effects are hypokalemia, agitation, and skin rashes - FALSE / INCORRECT ✓ (this is the EXCEPT answer)
  • Spironolactone causes HYPERKALEMIA (not hypokalemia) because it blocks aldosterone → prevents K⁺ secretion → K⁺ accumulates
  • Hypokalemia is the adverse effect of loop diuretics and thiazides, NOT spironolactone
  • Skin rashes can occur but are not the major concern
  • The characteristic adverse effects are: hyperkalemia, gynecomastia, menstrual irregularities, impotence
B. Its onset of action is slow, and the effects last for 2-3 days after the drug is discontinued - TRUE. Spironolactone has a slow onset (2-3 days to reach peak effect) because it must competitively displace aldosterone from its nuclear receptors and deplete existing proteins. Effects also persist 2-3 days after stopping.
C. It is also an androgen antagonist - TRUE. Spironolactone has significant anti-androgenic properties → used in treatment of hirsutism, acne, and polycystic ovarian syndrome in women; causes gynecomastia and impotence in men.
D. It is used in treatment of hirsutism in women - TRUE (follows from C above).
E. It is used in the treatment of primary aldosteronism - TRUE. Spironolactone is the drug of choice for Conn's syndrome (primary hyperaldosteronism) - it directly opposes the excess aldosterone effect.
Answer: A - because it states "hypokalemia" as an adverse effect, when the correct adverse effect is hyperkalemia. ✓
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Answer in detail

I can read all 10 questions clearly. Here are detailed answers:

Q1. Drug of choice for rapid relief of suspected coronary spasm characterized by sharp chest pain, shortness of breath, and a history of previous attacks?

Answer: B. Nitroglycerin

Explanation:

The clinical picture describes Prinzmetal's (vasospastic) angina - sharp chest pain with a history of previous attacks. This is caused by sudden coronary artery vasospasm rather than fixed atherosclerotic obstruction.
Nitroglycerin (GTN) is the drug of choice because:
  • It is an organic nitrate that releases nitric oxide (NO) in vascular smooth muscle
  • NO activates guanylyl cyclase → ↑ cGMP → smooth muscle relaxation → vasodilation of coronary arteries
  • Relieves the spasm within 1-3 minutes sublingually
  • Also reduces preload (venous dilation) and afterload (arterial dilation), reducing cardiac oxygen demand
Why not the others:
  • A. Pentobarbital sodium - a barbiturate sedative; has no effect on coronary vasospasm
  • C. Quinidine - antiarrhythmic (Class IA); no anti-spasm activity
  • D. Digitalis - positive inotrope; used in heart failure/atrial fibrillation; not for angina
  • E. Morphine - used in ACS (STEMI) for pain, but NOT for rapid relief of vasospasm; it's not the first-line drug here
Additional note: Calcium channel blockers (e.g., nifedipine, diltiazem, verapamil) are the mainstay of long-term prevention of Prinzmetal's angina. For acute relief, sublingual nitroglycerin is the drug of choice.

Q2. In edema related to congestive heart failure, the MOST effective and reliable diuretics are the:

Answer: A. Chlorothiazide (image shows A circled)
However, the correct pharmacological answer is LOOP DIURETICS (e.g., furosemide).

Explanation:

In CHF-related edema, the drug classes ranked by effectiveness:
Diuretic ClassEffectiveness in CHFWhy
Loop diuretics (furosemide, bumetanide, ethacrynic acid)Most effectiveBlock Na⁺/K⁺/2Cl⁻ cotransporter in thick ascending limb; work even with reduced GFR; can eliminate massive fluid overload
Thiazides (chlorothiazide, HCTZ)Moderate; become ineffective at GFR <30Block Na⁺/Cl⁻ cotransporter in distal tubule
K⁺-sparing (spironolactone)Mild; used as adjunct in CHF (mortality benefit)Block aldosterone receptor
Osmotic diureticsNOT used in CHFCan worsen fluid overload acutely
Xanthine diureticsMild; not used clinicallyMinimal clinical role
If the question accepts the circled answer A (chlorothiazide/thiazides), this may be a poorly written question. The correct answer based on standard pharmacology is loop diuretics - they are the MOST effective and reliable in CHF edema because:
  1. They work even when GFR is reduced (as in CHF)
  2. They can produce large volumes of urine to relieve acute pulmonary edema
  3. Furosemide also has acute venodilatory effects (before diuresis begins) that help in acute pulmonary edema
Spironolactone is added in CHF not primarily for diuresis but because it reduces mortality (aldosterone antagonism prevents cardiac remodeling).

Q3. A 30-year-old woman being treated for hypertension has sudden onset of fever, malaise, temperature 38.3°C (101°F), malar rash, swelling and tenderness of her wrists and knees, and a three-component friction rub at the left lower sternal border. The drug most likely to have caused these findings is:

Answer: E. Hydralazine

Explanation:

The clinical picture describes Drug-Induced Lupus Erythematosus (DILE):
  • Fever, malaise
  • Malar rash (butterfly rash over cheeks)
  • Polyarthritis (swollen, tender joints)
  • Pericardial friction rub (serositis - a hallmark of lupus)
These are the classic features of SLE and can be drug-induced.
Hydralazine is the #1 classic cause of drug-induced lupus, along with procainamide. The classic mnemonic is:
"SHIPP" drugs causing drug-induced lupus:
  • S - Sulfasalazine
  • H - Hydralazine (#1 classic)
  • I - Isoniazid
  • P - Procainamide (#1 by incidence)
  • P - Phenytoin
Mechanism: Hydralazine is metabolized by N-acetyltransferase. Slow acetylators accumulate the drug and are more susceptible to DILE. Hydralazine causes reactive oxygen species formation → DNA modifications → auto-antigen formation → autoimmune response.
Why not the others:
  • A. Propranolol - beta-blocker; rarely causes lupus
  • B. Captopril - ACE inhibitor; causes cough, angioedema, but not classic DILE
  • C. Minoxidil - causes hypertrichosis, fluid retention; not lupus
  • D. Nitroprusside - used for hypertensive emergency; cyanide toxicity is the concern, not lupus

Q4. Which one of the following drugs can be used in maintenance of patent ductus arteriosus before surgery?

Answer: B. Alprostadil

Explanation:

Patent ductus arteriosus (PDA) is the persistence of the fetal connection between the aorta and pulmonary artery after birth.
In certain duct-dependent congenital heart defects, keeping the ductus arteriosus OPEN is a lifesaving intervention before definitive surgery. Examples:
  • Transposition of the great arteries
  • Pulmonary atresia
  • Tricuspid atresia
  • Coarctation of the aorta
  • Hypoplastic left heart syndrome
Alprostadil (PGE₁ - Prostaglandin E₁) is used to MAINTAIN ductal patency:
  • It is a synthetic form of PGE₁
  • PGE₁ acts on EP receptors in ductal smooth muscle → cAMP ↑ → smooth muscle relaxation → ductus remains open
  • Given as a continuous IV infusion
Why the others are wrong:
  • A. Dinoprostoне (PGE₂) or carboprost (PGF₂α - "Protein 15M") - PGF₂α is actually a vasoconstrictor and can CLOSE the ductus; PGE₂ can maintain it but alprostadil (PGE₁) is the specific drug used
  • C. Thromboxane A₂ - potent vasoconstrictor and platelet aggregator; would CLOSE the ductus
  • D. Misoprostol - PGE₁ analog used for cervical ripening/ulcers/medical abortion; NOT used for ductal maintenance
To CLOSE a PDA (premature infants): use indomethacin or ibuprofen (NSAIDs that inhibit prostaglandin synthesis → ductus constricts and closes).

Q5. Phenylephrines may cause which cardiovascular effect? (Table given with Heart Rate, Contractility, Vasodilation, Vasoconstriction profiles)

Answer: D. Row 4

Explanation:

Phenylephrine is a pure α₁ agonist (no significant β activity).
Its cardiovascular profile:
ParameterEffectReason
Heart rateDECREASED (↓ or 0)α₁ stimulation → vasoconstriction → BP rises → reflex bradycardia via baroreceptors (vagal reflex)
ContractilityMild increase or 0Minimal direct cardiac effect (no β₁ activity); small indirect effect via myocardial α₁
Vasodilation0No β₂ activity; does not cause vasodilation
Vasoconstriction+++ to ++++Primary effect via α₁ receptors on arteriolar smooth muscle
From the table in the image, Row 4 shows: Heart Rate = 0 (or decrease), Contractility = ++++, Vasodilation = 0, Vasoconstriction = 0 to ++++.
The key identifying feature of phenylephrine: decreased heart rate (reflex bradycardia) + strong vasoconstriction + no vasodilation.
Clinical uses of phenylephrine:
  • Nasal decongestant (α₁ constriction of nasal vessels)
  • Hypotension (especially spinal anesthesia-induced hypotension)
  • Ophthalmology (pupil dilation for fundoscopy - stimulates iris dilator α₁ receptors)
  • Paroxysmal SVT (reflex vagal response from BP rise can terminate SVT)

Q6. Propranolol inhibits tachycardia caused by excessive epinephrine administration. Which of the following forms of drug antagonism is most likely associated with this situation?

Answer: C. Physiologic antagonism

Explanation:

Types of drug antagonism:
TypeDefinitionExample
Competitive (pharmacologic)Antagonist competes for the same receptor; reversible; can be overcome by more agonistAtropine vs. ACh at muscarinic receptors
Non-competitiveAntagonist binds irreversibly or at allosteric site; cannot be overcomePhenoxybenzamine vs. NE at α receptors
ChemicalAntagonist directly binds to and inactivates the agonist moleculeProtamine + heparin; dimercaprol + heavy metals
Physiologic (functional)Two drugs act on different receptors producing opposite physiological effectsPropranolol (β-blocker) vs. epinephrine
Propranolol vs. Epinephrine:
  • Epinephrine binds β₁ receptors on the heart → tachycardia
  • Propranolol blocks β₁ receptors → prevents tachycardia
  • They act on THE SAME receptor → this is actually competitive antagonism
However, if interpreted more broadly: epinephrine causes tachycardia via multiple mechanisms (β₁ direct + sympathetic activation), and propranolol opposes this via receptor blockade = pharmacologic/competitive antagonism at the β₁ receptor.
The question's circled answer is C (Physiologic antagonism) - this would apply if propranolol were acting through a DIFFERENT receptor/pathway to oppose tachycardia. In strict pharmacology, propranolol blocking the same β₁ receptor is competitive/pharmacologic antagonism. But in some curricula, blocking the receptor that mediates a physiological response is termed "physiologic antagonism."
The standard textbook answer is: Competitive (pharmacologic) antagonism - but the marked answer here is C. Physiologic antagonism.

Q7. Which of the following anticancer drugs has NOT a delayed toxicity?

Answer: D. Hydroxyurea

Explanation:

Delayed toxicity in anticancer drugs refers to toxicities that manifest weeks to months after treatment (e.g., cardiotoxicity, pulmonary fibrosis, secondary malignancies, bladder toxicity).
DrugDelayed Toxicity
A. MitoxantroneCardiotoxicity (delayed, dose-dependent; causes cardiomyopathy - similar to anthracyclines)
B. AmsacrineCardiotoxicity (arrhythmias, delayed cardiomyopathy)
C. AsparaginasePancreatitis, coagulopathy, hepatotoxicity (can be delayed)
D. HydroxyureaNo significant delayed toxicity - its toxicities are ACUTE: myelosuppression (which recovers quickly), mucositis, GI effects. No cumulative organ toxicity.
E. QuinacrineHas delayed toxicity (skin pigmentation, hepatotoxicity)
Hydroxyurea (ribonucleotide reductase inhibitor) causes predominantly acute and reversible myelosuppression. Unlike anthracyclines (doxorubicin → cumulative cardiotoxicity), bleomycin (→ pulmonary fibrosis), or cyclophosphamide (→ bladder carcinoma), hydroxyurea does NOT have significant cumulative/delayed organ toxicity.
Answer: D. Hydroxyurea

Q8. A 25-year-old man who has been depressed is found unresponsive by his wife. Physical examination discloses he is comatose without response to pain. The pupils are dilated and unreactive to light. The oral mucosa is dry. No bowel sounds are audible. The heart rate is 140/min, blood pressure 100/50 mmHg. An ECG shows right bundle branch block. Which of the following drugs is most likely to have been ingested?

Answer: C. Amitriptyline (image shows A circled as "Phenelzine" but the clinical picture points to C)

Explanation:

The clinical picture is the classic tricyclic antidepressant (TCA) overdose:
FindingMechanism in TCA toxicity
ComaCNS depression
Dilated pupils (mydriasis)Anticholinergic effect (muscarinic blockade)
Dry mucosaAnticholinergic effect
No bowel soundsAnticholinergic (decreased GI motility)
Tachycardia (HR 140)Anticholinergic (blocks vagal slowing) + NE reuptake inhibition
Hypotensionα₁ blockade → vasodilation
Right bundle branch block / wide QRS on ECGPATHOGNOMONIC - TCAs block cardiac fast Na⁺ channels → slowed conduction → widened QRS, RBBB, QTc prolongation → risk of fatal arrhythmias
This constellation = TCA overdose, and amitriptyline is the classic TCA associated with this picture.
Why not the others:
  • A. Phenelzine - MAO inhibitor; causes hypertensive crisis (not hypotension), hyperthermia, tremors; no ECG changes typical of TCA
  • B. Alprazolam - benzodiazepine; causes CNS depression, respiratory depression, but NO anticholinergic signs, NO ECG changes
  • C. Amitriptyline - CORRECT ✓ - classic TCA overdose
  • D. Trazodone - atypical antidepressant; causes sedation, priapism; minimal anticholinergic/ECG effects
  • E. Lithium - causes tremor, polyuria, nephrogenic DI, ECG changes (T-wave flattening); NOT this picture
Treatment of TCA overdose: Sodium bicarbonate (to correct acidosis and narrow QRS), supportive care, activated charcoal if early.

Q9. Cyanide is toxic because it inhibits:

Answer: A. Cytochrome oxidase

Explanation:

Cyanide (CN⁻) is one of the most potent acute cellular toxins.
Mechanism: Cyanide binds with high affinity to the Fe³⁺ (ferric) form of Cytochrome c oxidase (Complex IV) in the mitochondrial electron transport chain (ETC).
Effect:
  • Complex IV is the terminal enzyme of the ETC → it transfers electrons to O₂ (final electron acceptor) to form H₂O
  • When cyanide inhibits Complex IV → electrons cannot be passed to oxygen → ETC is completely blocked
  • NADH and FADH₂ cannot be re-oxidized → oxidative phosphorylation halts
  • No ATP is produced → cells die despite adequate oxygen delivery ("histotoxic hypoxia")
  • Venous blood remains fully oxygenated (cells can't use O₂) → cherry-red venous blood
Why not the others:
  • B. Pyruvate dehydrogenase - inhibited by arsenic (arsenic poisoning); not cyanide
  • C. Phosphorylase - involved in glycogen breakdown; not the cyanide target
  • D. NADH dehydrogenase (Complex I) - inhibited by rotenone; not directly by cyanide
  • E. Succinate dehydrogenase (Complex II) - inhibited by malonate; not cyanide
Treatment of cyanide poisoning:
  1. Hydroxocobalamin (binds CN⁻ → cyanocobalamin)
  2. Sodium thiosulfate (converts CN⁻ to thiocyanate via rhodanese)
  3. Sodium nitrite (induces methemoglobin, which competes with cytochrome oxidase for CN⁻)
  4. Dicobalt edetate

Q10. A 62-year-old man with chronic obstructive pulmonary disease begins therapy with an antihypertensive drug. Two weeks later he has marked worsening of dyspnea and clearly audible wheezing. Select the drug most likely to cause this adverse effect:

Answer: A. Propranolol

Explanation:

The adverse effect described is bronchospasm/bronchoconstriction in a COPD patient.
Propranolol is a non-selective β-blocker (blocks both β₁ and β₂ receptors).
  • β₂ receptors in bronchial smooth muscle mediate bronchodilation (sympathetic relaxation)
  • Blocking β₂ receptors → bronchoconstriction → worsening dyspnea and wheezing
  • In COPD/asthma patients, this can precipitate life-threatening bronchospasm
  • Non-selective beta-blockers are CONTRAINDICATED in COPD and asthma
Why not the others:
  • B. Furosemide - loop diuretic; not an antihypertensive that causes bronchoconstriction (IV furosemide can rarely cause bronchospasm but not markedly)
  • C. Verapamil - calcium channel blocker; does NOT cause bronchospasm; actually can cause constipation, bradycardia, heart block
  • D. Atenolol - cardioselective β₁ blocker; preferentially blocks β₁ (cardiac) >> β₂ (lung); while it should still be used cautiously in severe COPD, it is much less likely to cause significant bronchospasm than propranolol
  • E. Procainamide - antiarrhythmic (Class IA); does not cause bronchospasm
Key teaching point: In a hypertensive patient with COPD/asthma who needs a beta-blocker:
  • Avoid propranolol (non-selective)
  • If a beta-blocker is absolutely necessary, use a cardioselective one (atenolol, metoprolol, bisoprolol) at low doses
  • Preferred antihypertensives in COPD: ACE inhibitors, ARBs, calcium channel blockers, thiazides
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Answer in detail

Here are detailed answers to all 10 questions:

Q1. Which of the following is NOT true regarding smooth muscle which forms the arterial wall?

Answer: A. The sodium channels are primary activated in depolarization

Explanation:

In vascular smooth muscle, the physiology of excitation-contraction coupling is fundamentally different from skeletal muscle:
What IS true (correct statements):
  • B. Receptor-activated channels use a messenger (e.g. cAMP) to effect response - TRUE. Vascular smooth muscle uses second messengers extensively. cAMP (via β₂ receptors) → PKA activation → myosin light chain kinase (MLCK) phosphorylation → relaxation. Also IP₃/DAG via α₁ receptors.
  • C. Calcium channels open when smooth muscle is depolarized - TRUE. L-type (voltage-gated) Ca²⁺ channels open upon depolarization → Ca²⁺ influx → calmodulin-Ca²⁺ complex → activates MLCK → contraction.
  • D. Beta adrenergic channels are inhibitory and produce vasodilation - TRUE. β₂ receptor stimulation → ↑ cAMP → PKA activates → MLCK is inhibited + K⁺ channels open → hyperpolarization → vasodilation.
  • E. Alpha adrenergic receptors are excitatory and produce vasoconstriction - TRUE. α₁ stimulation → Gq → PLC → IP₃ → Ca²⁺ release from SR + DAG → PKC → contraction.
What is NOT true:
  • A. Sodium channels are primarily activated in depolarization - FALSE in smooth muscle. Unlike cardiac and skeletal muscle where fast Na⁺ channels drive the rapid upstroke of the action potential, in vascular smooth muscle, the depolarization is driven primarily by Ca²⁺ influx through L-type Ca²⁺ channels (slow channels), NOT by Na⁺ channels. Na⁺ channels play a minimal role in smooth muscle depolarization.

Q2. A 62-year-old man with COPD begins therapy with an antihypertensive drug. Two weeks later he has marked worsening of dyspnea and clearly audible wheezing. Select the drug most likely to cause this adverse effect:

Answer: A. Propranolol
(This question appeared in the previous set - detailed explanation already given)
Key points:
  • Propranolol is a non-selective β-blocker (blocks β₁ + β₂)
  • β₂ blockade in bronchial smooth muscle → bronchoconstriction → worsening dyspnea and wheezing
  • Non-selective beta-blockers are contraindicated in COPD and asthma
  • Atenolol (D) is cardioselective (β₁ preferential) and much less likely to cause this
  • Verapamil (C), furosemide (B), and procainamide (E) do not cause bronchospasm

Q3. Central blood volume is:

Answer: E. Increased by blood transfusion

Explanation:

Central blood volume (CBV) refers to the blood volume contained in the heart chambers and pulmonary vasculature (the "central" cardiopulmonary circuit). It determines cardiac preload.
Analysis of each option:
  • A. Increased by standing upright from lying down - FALSE. When you stand up, gravity pulls blood into the lower extremities and splanchnic veins → venous poolingdecreased venous return → decreased CBV. This is why cardiac output drops momentarily on standing (orthostatic hypotension).
  • B. Increased by positive pressure breathing - FALSE. Positive pressure ventilation (e.g., PEEP in mechanical ventilation) increases intrathoracic pressure → compresses great veins and heart → decreases venous return → decreases CBV. This is why high PEEP reduces cardiac output.
  • C. Decreased by the weightlessness of space flight - FALSE. In weightlessness (microgravity), the normal gravitational pooling of blood in the lower extremities is abolished → blood shifts toward the thorax and headincreases CBV. Astronauts experience facial puffiness and increased urinary output early in spaceflight as the body compensates for the increased CBV.
  • D. Unaffected by the Valsalva maneuver - FALSE. The Valsalva maneuver (forced expiration against a closed glottis) increases intrathoracic pressure → impedes venous return → decreases CBV significantly.
  • E. Increased by blood transfusion - TRUE ✓. Adding blood volume directly increases total circulating blood volume → more blood returns to the heart → increases CBV and preload → increases cardiac output (Frank-Starling mechanism).

Q4. The duration of a ventricular myocyte action potential is:

Answer: A. Nearly as long as the refractory period

Explanation:

This is one of the most physiologically important distinctions between cardiac and skeletal muscle.
Ventricular action potential duration:
  • Lasts approximately 200-400 ms (at a normal heart rate of 70 bpm)
  • Consists of 5 phases: Phase 0 (rapid upstroke), Phase 1 (early repolarization), Phase 2 (plateau - unique to cardiac muscle), Phase 3 (rapid repolarization), Phase 4 (resting)
The absolute refractory period (ARP) of ventricular myocytes:
  • Spans from Phase 0 through most of Phase 3 → approximately 200-250 ms
  • The ARP covers almost the entire duration of the action potential
Why A is correct:
  • The cardiac action potential duration (~250-300 ms) is nearly co-extensive with the absolute refractory period (~200-250 ms)
  • This prevents summation and tetanic contraction of heart muscle - the heart CANNOT be tetanized (unlike skeletal muscle), which is essential for rhythmic, efficient pumping
  • The long plateau phase (Phase 2, due to L-type Ca²⁺ channels) is responsible for this prolonged action potential
Why the others are wrong:
  • B. Twice as long as in skeletal muscle - Wrong. Skeletal muscle AP lasts ~1-2 ms; cardiac AP lasts ~200-400 ms → cardiac is ~100-200× longer than skeletal, not just twice
  • C. As long in duration as the QRS complex - Wrong. QRS lasts only ~80-120 ms; the ventricular AP lasts ~250-300 ms. The QT interval more closely represents the ventricular AP duration
  • D. Approximately twice as long as the relative refractory period - Wrong. The relative refractory period is a brief period at the end of Phase 3; the AP is much longer than twice the RRP

Q5. The minimum stimulus necessary to produce a specific sensation is called the:

Answer: C. Absolute threshold

Explanation:

Sensory thresholds - definitions:
TermDefinition
Absolute thresholdThe minimum intensity of a stimulus required to produce a conscious sensation 50% of the time in a given sensory modality. It is the lower boundary of perception.
Difference threshold (JND - Just Noticeable Difference)The minimum change in stimulus intensity needed to detect a difference between two stimuli. Governed by Weber's Law: ΔI/I = constant.
Transduction thresholdNot a standard psychophysics term; refers to when a stimulus is converted to a neural signal (receptor potential) - happens BELOW the conscious perception threshold
Adaptation thresholdNot a standard term; adaptation = decreased response to a sustained stimulus
Detection thresholdSometimes used synonymously with absolute threshold
The question specifically asks for the minimum stimulus to "produce a specific sensation" = Absolute threshold (C)
Note: Transduction can occur below the absolute threshold (the receptor can be activated but the signal doesn't reach conscious awareness). The absolute threshold is where conscious perception begins.

Q6. During exercise or stress, which one of the following cardiovascular system reserves has the largest potential for increasing O₂ supply to the tissue?

Answer: E. Increased blood flow resulting from increased stroke volume

Explanation:

O₂ delivery to tissues = Cardiac Output × Arterial O₂ content
During exercise, the body uses several reserves to increase O₂ delivery:
Reserve MechanismPotential magnitudeNotes
A. Increased O₂ extraction from bloodLimited (2-3×)Resting O₂ extraction ~25%; maximum ~75-80%; so only 3-fold reserve
B. Increased arterial blood pressureModestBP increases only moderately during exercise; not the primary reserve
C. Increased blood arterial O₂ contentVery limitedResting arterial blood is already ~98% saturated; minimal room to increase
D. Increased venous blood pressureNot a meaningful O₂ reserve
E. Increased blood flow (cardiac output via increased stroke volume + HR)Largest (5-7×)Cardiac output can increase from ~5 L/min at rest to 25-35 L/min during maximal exercise in trained athletes - a 5-7 fold increase
Cardiac output (CO = HR × SV) is the dominant reserve:
  • Heart rate can increase from 70 → 180-200 bpm
  • Stroke volume increases via Frank-Starling mechanism and increased contractility
  • The combined effect gives a massive increase in blood flow to exercising muscles
  • This dwarfs all other reserves
Answer: E ✓ - increased blood flow via increased cardiac output (stroke volume × heart rate) has the greatest potential for increasing O₂ supply.

Q7. The normal range for color, saturation, and volume indices is:

Answer: D. 0.9-1.1

Explanation:

In hematology, erythrocyte (red blood cell) indices are used to classify anemias. These indices are normalized so that the normal value = 1.0 (or expressed as a range of 0.9-1.1):
Red cell indices:
IndexWhat it measuresNormal ValueNormal Range
Color Index (CI)Hemoglobin content per cell relative to normal1.00.9-1.1
Saturation IndexConcentration of Hb in RBC (related to MCHC)1.00.9-1.1
Volume Index (VI)Size of RBC relative to normal (related to MCV)1.00.9-1.1
These indices are expressed as ratios relative to the normal standard:
  • < 0.9 = hypochromic (color) or microcytic (volume) → iron deficiency anemia
  • 0.9-1.1 = normochromic/normocytic (normal)
  • > 1.1 = hyperchromic or macrocytic → megaloblastic anemia
Answer: D. 0.9-1.1
The other options are incorrect: 1.3-2.0 or 2.0-2.8 would indicate macrocytic/hyperchromic states; 0.5-0.8 would indicate severe hypochromia/microcytosis.

Q8. The mean pressure is the average pressure throughout the cardiac cycle. It can be calculated as:

Answer: A. Diastolic pressure plus one-third of the pulse pressure
(Note: The image shows option A, though it reads "systolic pressure plus one-third..." - the correct formula uses diastolic.)

Explanation:

Mean Arterial Pressure (MAP) is the time-averaged pressure in the arteries throughout the cardiac cycle.
Formula:
MAP = Diastolic BP + 1/3 × Pulse Pressure
Or equivalently:
MAP = Diastolic BP + 1/3 × (Systolic BP - Diastolic BP)
Or the most commonly memorized form:
MAP = (Systolic BP + 2 × Diastolic BP) / 3
Why diastolic + 1/3 pulse pressure?
  • At a normal heart rate, the heart spends approximately 2/3 of the cardiac cycle in diastole and 1/3 in systole
  • Therefore, the average pressure is closer to diastolic than to systolic
  • The contribution of systole to the mean = 1/3 of the pressure difference (pulse pressure)
Example: BP = 120/80 mmHg
  • Pulse pressure = 120 - 80 = 40 mmHg
  • MAP = 80 + (1/3 × 40) = 80 + 13.3 = 93.3 mmHg
Or: (120 + 2×80)/3 = (120 + 160)/3 = 280/3 = 93.3 mmHg
Why the others are wrong:
  • B. Diastolic + 1/3 pulse pressure - this IS the correct formula (likely what A should read)
  • C. Systolic minus 1/3 pulse pressure = 120 - 13.3 = 106.7 (WRONG - too high)
  • D. Difference between systolic and diastolic = pulse pressure, NOT MAP

Q9. Decreasing the radius of a vessel by one-half its original radius will have what effect upon blood flow?

Answer: D. Blood flow will decrease to 6.25% of original flow (the image shows D circled but the label says "25%")

Explanation:

This is an application of the Hagen-Poiseuille Law:
Q = (π × r⁴ × ΔP) / (8 × η × L)
Where Q = flow, r = radius, ΔP = pressure gradient, η = viscosity, L = length.
The critical relationship: Flow is proportional to the FOURTH POWER of the radius (r⁴)
If radius is halved (r → r/2):
  • New flow = Q × (r/2)⁴ / r⁴
  • New flow = Q × (1/2)⁴
  • New flow = Q × 1/16
  • New flow = 6.25% of original flow
This means reducing the vessel radius by half reduces blood flow to only 1/16th (6.25%) of its original value.
This is the physiological basis for why:
  • Coronary artery stenosis has such dramatic effects on flow
  • Even modest vasoconstriction (reducing radius by 10-20%) significantly reduces organ perfusion
  • Atherosclerotic plaques need to reduce lumen area substantially before flow is critically affected
The marked answer D says "25%" - this would correspond to halving only the cross-sectional area (r²), not the flow (r⁴). The mathematically correct answer is 6.25% (1/16th).

Q10. Lymph flow from the foot is:

Answer: C. Increased when an individual rises from the supine to the standing position (marked answer)

Explanation:

Lymph flow is driven by:
  1. Capillary filtration (Starling forces)
  2. Lymphatic vessel contractions
  3. Skeletal muscle pumping
  4. Respiratory movements
  5. Arterial pulsations
Analysis of each option:
  • A. Increased when capillary permeability is decreased - FALSE. Less permeability → less fluid leaks into interstitium → less lymph formed → DECREASED lymph flow.
  • B. Decreased when the valves of the leg veins are incompetent - FALSE. Incompetent venous valves → venous hypertension → increased capillary hydrostatic pressure → more fluid leaks into interstitium → increased lymph formation and flow (lymphatic system works harder). Chronic venous insufficiency causes lymphedema when the lymphatics are overwhelmed.
  • C. Increased when an individual rises from the supine to standing - TRUE (marked answer) ✓. When standing, hydrostatic pressure in foot capillaries increases significantly (by ~80 mmHg from the column of blood) → increased capillary filtration → more interstitial fluid → more lymph must be formed and drained from the foot.
  • D. Decreased in exercise - FALSE. Exercise increases muscle pump activity, blood flow, and capillary filtration → increases lymph flow significantly.
  • E. Increased when the foot is massaged - TRUE (this was discussed in the earlier batch). Massage mechanically propels lymph forward.
The marked answer C is correct - standing increases capillary hydrostatic pressure in the foot → more filtration → more lymph production and flow from the foot.Here are detailed answers to all 7 questions:

Q1. Which of the following tests is NOT related to blood coagulation?

Answer: A. Erythrocyte fragility

Explanation:

Blood coagulation tests assess the clotting cascade, platelet function, and hemostasis:
  • B. Prothrombin time (PT) - measures the extrinsic + common pathway (Factors VII, X, V, II, fibrinogen); used to monitor warfarin therapy; expressed as INR. Related to coagulation ✓
  • C. Platelet count - platelets are the first responders in primary hemostasis (platelet plug formation); low count → thrombocytopenia → bleeding. Related to coagulation ✓
  • D. Coagulation time (Lee-White clotting time) - measures the time for whole blood to clot in a test tube; assesses the intrinsic pathway. Related to coagulation ✓
  • A. Erythrocyte (osmotic) fragility test - measures the resistance of red blood cells to lysis when placed in hypotonic saline solutions. It tests the membrane integrity and shape of RBCs, not clotting. It is used to diagnose:
    • Hereditary spherocytosis (increased fragility - RBCs lyse easily)
    • Iron deficiency anemia (decreased fragility - flat RBCs resist osmotic lysis)
    • Thalassemia (decreased fragility)
    • This test has nothing to do with the coagulation cascade or hemostasis
Answer: A. Erythrocyte fragility ✓ - it tests RBC membrane stability, not blood clotting.

Q2. Total resistance of a number of resistances in a series of a vascular system is equal to:

Answer: A. The sum of each individual resistance

Explanation:

This tests knowledge of series vs. parallel resistance in vascular circuits.
Series circuit (vessels connected end-to-end):
R_total = R₁ + R₂ + R₃ + ... + Rₙ
Total resistance = SUM of all individual resistances
Example: Aorta → arteries → arterioles → capillaries → venules → veins are all in series. Total systemic vascular resistance = the additive sum of resistance at each level.
Parallel circuit (vessels branching side-by-side):
1/R_total = 1/R₁ + 1/R₂ + 1/R₃ + ...
The total resistance in parallel is LESS than any individual resistance (adding parallel vessels reduces total resistance).
Why the other options are wrong:
  • B. The product of the reciprocal of each individual resistance - this is not a standard formula
  • C. The sum of the reciprocals - this applies to parallel circuits (giving 1/R_total), not series
  • D. The largest individual resistance - incorrect; all resistances add up in series
  • E. The product of each individual resistance - incorrect formula
Clinical relevance: Most organ circulations are arranged in parallel (kidney, brain, gut, limbs all receive blood simultaneously from the aorta), which means adding more organs to the circulation DECREASES total vascular resistance. The individual vessels within each organ are in series.
Answer: A

Q3. Which of the following statements correctly describes baroreceptors?

Answer: B. When stimulated, baroreceptors will cause a reduction in heart rate

Explanation:

Baroreceptors are mechanoreceptors (stretch receptors) located in the:
  • Carotid sinus (at bifurcation of common carotid artery) - innervated by CN IX (Hering's nerve)
  • Aortic arch - innervated by CN X (vagus nerve)
They respond to wall stretch caused by increased blood pressure.
Analysis of each option:
A. Baroreceptors are inactive in patients with hypertension - FALSE. In chronic hypertension, baroreceptors reset to operate at a higher pressure set point. They remain active but are calibrated to the new higher pressure range. They do not become inactive.
B. When stimulated, baroreceptors will cause a reduction in heart rate - TRUE ✓
  • High BP → stretch of baroreceptor → increased afferent firing → nucleus tractus solitarius in medulla → increased parasympathetic (vagal) output + decreased sympathetic output
  • Result: bradycardia (↓ HR), vasodilation, ↓ BP
  • This is the classic baroreceptor reflex (baroreflex)
C. Baroreceptors do not discharge at blood pressures within the normal range - FALSE. Baroreceptors have a threshold around 60-80 mmHg and fire tonically throughout the normal pressure range (80-180 mmHg). Their firing rate is proportional to pressure. They maintain constant baseline parasympathetic tone.
D. Baroreceptors are only responsive to high pressure - FALSE. They respond to any change in arterial wall stretch, including decreases in blood pressure (hypotension → decreased firing → reflex tachycardia and vasoconstriction).
E. Activation of the baroreceptors promotes sympathetic discharge - FALSE. This is the opposite. Baroreceptor activation INHIBITS sympathetic discharge and ENHANCES parasympathetic activity to lower BP and HR.
Answer: B

Q4. Decreasing the radius of a vessel by one-half its original radius will have what effect upon blood flow?

Answer: B. Blood flow will decrease to 6% of original flow (mathematically it is 6.25%, closest to option B)

Explanation:

Applying the Hagen-Poiseuille Law:
Q ∝ r⁴ (Flow is proportional to the FOURTH POWER of radius)
If r is reduced to r/2:
  • New Q = Q_original × (r/2)⁴ / r⁴
  • New Q = Q_original × (1/2)⁴
  • New Q = Q_original × 1/16
  • New Q = 6.25% of original flow
This is a fundamental principle of vascular physiology:
Radius changeFlow change
×2 (double radius)×16 (16× more flow)
×½ (half radius)×1/16 (6.25% of original)
×⅔×(2/3)⁴ = 0.197 = ~20%
Option B (6%) is the closest to the correct mathematical answer of 6.25%.
Clinical significance:
  • This is why vasoconstriction is so powerful - small changes in arteriolar radius produce massive changes in flow
  • A 20% reduction in arteriolar radius → flow drops to ~41% of normal
  • Coronary artery spasm reducing radius by 50% → devastating reduction in myocardial blood supply
  • This is also why vasodilators (like nitrates, calcium channel blockers) are so effective - small increases in radius dramatically increase flow

Q5. Lymph flow from the foot is:

Answer: C. Increased when an individual rises from the supine to the standing position
(This question has appeared in the previous batch - detailed explanation given. Summary below:)

Explanation:

  • A. Increased when capillary permeability is decreased - FALSE. Less permeability → less filtration → less lymph
  • B. Decreased when leg vein valves are incompetent - FALSE. Incompetent valves → venous hypertension → MORE filtration → MORE lymph flow
  • C. Increased when rising from supine to standing - TRUE ✓. Standing raises hydrostatic pressure in foot capillaries by ~80 mmHg → greatly increased capillary filtration → more interstitial fluid formed → lymphatic system must drain more → lymph flow INCREASES
  • D. Decreased in exercise - FALSE. Exercise → muscle pump → increases lymph flow
  • E. Increased when foot is massaged - TRUE (also correct, but C is marked)
Answer: C

Q6. Decreasing the radius of a vessel by one-half its original radius will have what effect upon blood flow? (repeated question, marked D = 25%)

Mathematical answer: B. Blood flow will decrease to 6% of original flow (6.25% exactly)
The marked answer D (25%) is incorrect mathematically. Here is why 25% is wrong:
  • 25% would be if flow were proportional to (cross-sectional area): (1/2)² = 1/4 = 25%
  • But flow follows r⁴ (Poiseuille): (1/2)⁴ = 1/16 = 6.25%
The difference between r² and r⁴ is critical - resistance (viscous friction) depends not just on cross-sectional area but on the velocity gradient across the tube, which makes the r⁴ relationship emerge.
Correct answer: B. 6% (6.25% precisely)

Q7. The mean pressure is the average pressure throughout the cardiac cycle. It can be calculated as:

Answer: B. Diastolic pressure plus one-third of the pulse pressure
(The image shows A circled, but option A reads "systolic pressure plus one-third of the pulse pressure" which is incorrect. The correct formula uses diastolic pressure.)

Explanation:

Mean Arterial Pressure (MAP) formula:
MAP = Diastolic BP + ⅓ × (Systolic BP - Diastolic BP) MAP = Diastolic BP + ⅓ × Pulse Pressure
Why this formula works:
  • The heart spends ~⅔ of the cardiac cycle in diastole and ~⅓ in systole at normal heart rates
  • Therefore, the time-averaged pressure is weighted toward diastolic
  • The systolic "boost" contributes only 1/3 of the pulse pressure to the mean
Numerical example:
  • BP = 120/80 mmHg; Pulse pressure = 40 mmHg
  • MAP = 80 + (40/3) = 80 + 13.3 = 93.3 mmHg
  • Alternatively: (120 + 2×80) / 3 = 280/3 = 93.3 mmHg
Normal MAP: 70-100 mmHg (minimum of ~60 mmHg needed to perfuse vital organs like kidneys and brain)
Why the other options are wrong:
  • A. Systolic + ⅓ pulse pressure = 120 + 13.3 = 133.3 mmHg - far too high, WRONG
  • C. Systolic minus ⅓ pulse pressure = 120 - 13.3 = 106.7 mmHg - still too high, WRONG
  • D. Difference between systolic and diastolic = 120 - 80 = 40 mmHg - this is the pulse pressure, NOT MAP
Answer: B. Diastolic pressure plus one-third of the pulse pressure
This is a shared conversation. Sign in to Orris to start your own chat.